Publication | Closed Access

Strategy for enhancing the therapeutic efficacy of histone deacetylase inhibitor dacinostat: the novel paradigm to tackle monotonous cancer chemoresistance

Novel ParadigmMonotonous Cancer ChemoresistanceMedicinePharmacologyTherapeutic EfficacyAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyCancer ResearchTumor BiologyCancer Growth